Dutch regulator calls for shelf life after opening to be listed on OTC packaging

15 October 2016

The Netherlands Medicines Evaluation Board (MEB) wants manufacturers of over-the-counter medicinal products to list the shelf life after opening on the packaging.

This is a response to an investigation by the Consumers’ Association in 2015 which shows that this information is often missing from re-sealable packaging of OTC medicines, for instance on some bottles containing cough medication.

According to European legislation it is not always necessary to list the shelf life after opening on the packaging. In order to ensure that medicines are used properly, the MEB considers it important that this does happen. In the new rules the MEB therefore asks manufacturers always to list the shelf life after opening on the packaging of re-sealable OTC medicinal products.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK